Navigation Links
Physicians Rank Schering-Plough's Marketing Messages for Asmanex as the Most Appealing in the Asthma Drug Market
Date:11/5/2008

ter this clinical scenario."

About Brands & Strategies

The Brands & Strategies report series from Decision Resources reveals what it takes to be successful in a pharmaceutical market. It offers the most comprehensive commercial analysis of the brands and strategies of competing companies so they can better position themselves in a market and plan future strategy based on what competitors are doing. Brands & Strategies is the first and only report series to bring together all the competitive information elements pharma companies need to make informed decisions about their brands and next-steps.

About Decision Resources

Decision Resources, Inc., (http://www.DecisionResources.com) is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Heather Hilty Elizabeth Marshall

Decision Resources Decision Resources, Inc.

781-296-2536 781-296-2563

hhilty@dresources.com emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Psychiatrists are the least religious of all physicians
4. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
5. Scientists, physicians present latest findings in personalized cancer treatment and prevention
6. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
7. U.S. Physicians Question Presidential Candidates
8. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
9. Internal medicine physicians recommend key elements to guide state initiatives
10. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
11. American College of Physicians publishes The Fenway Guide to LGBT Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... ORLEANSA drug that has become a mainstay of ... re-establishing the immune system of patients who have ... donors, according to early clinical trial results to ... investigators at the American Society of Hematology,s (ASH) ... Ernest N. Morial Convention Center, Room 243-245, 5:45 ...
(Date:12/6/2009)... 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the pivotal Phase 2b 003-A1 study, known as ... in heavily pre-treated relapsed and refractory multiple myeloma ... ASH/ASCO Joint Symposium at the 51st annual meeting ... New Orleans. Enrollment in this trial is complete ...
(Date:12/6/2009)... the community, in cooperation with the Greater VA Healthcare System in ... year,s attendance is expected to soar to more than 5,000 veterans, ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of ... West Los Angeles, will once again create a holiday party. This ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... Executive Director of the Iowa Chronic Care Consortium, is ... ... NORTHFIELD, Ill., March 6 Today Pharos Innovations, a,remote ... conditions, announced the first recipient of a new award ...
... Researchers have for the first time cleared an important ... Neutropenia (SCN), a deadly disease characterized by a deficiency ... cell important to fighting infection and disease. A research ... in the March 14 Immunity the first evidence of ...
... LDG ) today reported preliminary total retail drug,store sales of $379 million for the four-week period ended ... (Dollars in millions) ... ... ...
... March 6, 2008 A study released ... Alto Healthcare System in California shows that non-polypoid colorectal ... Americans than previously thought and may have a greater ... more commonly diagnosed colorectal polyp. The study appears in ...
... PITTSBURGH, March 6 Statement from Chuck,Mohan, ... Mitochondrial Disease,Foundation on reports of possible links ... are no scientific studies documenting that childhood,vaccinations ... is very,little scientific research in this area. ...
... March 6 SpectraCell Laboratories, Inc.,announced that the ... to its scientific,staff as Manager of Research & ... from the University of Texas,M.D. Anderson Cancer Center. ... of cellular and molecular biology research, as well ...
Other Medicine News:Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 2Health News:Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research 3Health News:Function of molecular switch pinpointed in severe congenital neutropenia 2Health News:Function of molecular switch pinpointed in severe congenital neutropenia 3Health News:Longs Reports Preliminary February Retail Drug Store Sales 2Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories 2
(Date:12/4/2009)... (NYSE Amex: PIP ), a biodefense company developing ... the presentation of new data from the Company,s anthrax ... (rPA) based anthrax vaccine is structurally stable and potent ... including 55 degrees C. The data were presented ...
(Date:12/4/2009)... tin cans and car trunks ,, WASHINGTON, Dec. ... Senate to defeat the Dorgan Importation plan encompassed in SA ... is poised to open our borders, allowing our safe, closed ... endangered. We could soon be getting drugs that were ...
(Date:12/4/2009)... Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary ... the initial development and successful testing of a novel ... believes this proprietary optical engine design raises the bar ... designs for swept source OCT light sources. This ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Want Sun Protection 3F Wear Red or Blue 59575 1NSF authorizes 2429 million for preliminary design of worlds deepest underground laboratory 10387 1NSF authorizes 2429 million for preliminary design of worlds deepest underground laboratory 10387 2NSF authorizes 2429 million for preliminary design of worlds deepest underground laboratory 10387 3Fruit fly pest identified in wine grapes 10385 1Fruit fly pest identified in wine grapes 10385 2Fruit fly pest identified in wine grapes 10385 3Fruit fly pest identified in wine grapes 10385 4
... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Administration (FDA) has issued an approvable letter for,the ... patients with community-acquired pneumonia (CAP)., Before granting ... to support the safety and efficacy of TYGACIL ...
... in ... treatment-experienced patients -, BRISBANE, Calif., May 29 InterMune, ... dosing in its Phase 1b,clinical trial evaluating ITMN-191, designated R7227 ... and,Copegus(R) (ribavirin) in treatment-naive patients infected with chronic,hepatitis C virus ...
Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 2InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 3InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 4
... Siemens Medical Solutions is a comprehensive modular ... disease. Urodiagnostics, endourology, lithotripsy, prostate diagnostics and ... part of a urologists responsibilities on a ... that supports the various diagnostic or therapeutic ...
... SLX is not only one of the most ... medical workstation. Apart from being designed for the ... the urinary tract, the MODULITH SLX can also ... therapies. It is equally suitable for the treatment ...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only....
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
Medicine Products: